This post was originally published by Myasthenia Gravis News A 60-year-old man being treated for multiple myeloma was found to...
Myeloma NZ
Cho Provides Background on the Multiple Myeloma Research Foundation’s CureCloud Study
This story was originally published by Targeted Oncology Hearn Jay Cho, MD, PhD, chief medical officer, Multiple Myeloma Research Foundation (MMRF),...
Gut Microbiome Could Play Key Role in Multiple Myeloma
This was originally published by AJMC The bone marrow (BM) microenvironment is believed to play a key role in the evolution of monoclonal gammopathy...
HealthTree® Launches HealthTree University for Multiple Myeloma Patients
This was originally posted by Cision PR Newswire SALT LAKE CITY, July 9, 2020 /PRNewswire/ -- HealthTree®, the first online portal...
FDA Places MELANI-01 Study for Multiple Myeloma on Hold After Safety Report Submission
This article was originally published by Cancer Network Cellectis recently announced the FDA placed its MELANI-01 trial treating multiple myeloma on...
Patients with Multiple Myeloma and CHIP Face Worse Outcomes Following ASCT
However, when followed by immunomodulatory drugs, researchers found that autologous stem cell transplant can be safely used in this patient...
Once-weekly selinexor regimen extends PFS in pretreated multiple myeloma
This article was originally published by Healio Once-weekly selinexor, bortezomib and dexamethasone improved outcomes compared with twice-weekly...
CAR T-Cell Therapies Show Promise for Multiple Myeloma, but Hurdles Remain
This article was originally published by AJMC There are promising signs that chimeric antigen receptor (CAR) T-cell therapies might lead to...
Dr. Kumar on Stem Cell Mobilization in Multiple Myeloma
This article originally published by OncLive Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses stem cell mobilization multiple...
Ninlaro Maintenance Therapy Improves Survival in Patients Not Given ASCT, Trial Shows
First-line maintenance therapy with Ninlaro (ixazomib) significantly delays disease progression or death in adults with multiple...
Multiple myeloma triple therapy now on PBS
This article was originally published by Hostpital and Healthcare. Australians with newly diagnosed multiple myeloma (MM) can now access a treatment...
Subcutaneous vs intravenous daratumumab in patients with relapsed or refractory multiple myeloma.
Background | Intravenous daratumumab for treatment of patients with multiple myeloma involves a lengthy infusion that affects quality of life, and...